Clinical trials
Mycobacterium Tuberculosis clinical trials
Below are recruiting mycobacterium tuberculosis clinical trials, each written for real people, not researchers. We’re tracking 13 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06439810Recruiting
TB detection test for new pleural fluid buildup
This study tests a new blood or fluid test (cell-free DNA) to find tuberculosis (TB) in people who have new fluid buildup around their lungs. If you are 18 or older and scheduled for a procedure to drain that fluid, you may be able to join.
Shatin, Hong KongAges 18 years+ - NCT06845618Recruiting
Blood test to monitor tuberculosis treatment
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
TakAges 18 years+ - NCT05610098Recruiting
Study of gene activity in spinal tuberculosis
This trial looks at patterns of gene activity (from blood/tissue samples) in adults with spinal tuberculosis. The goal is to better understand the disease and how to tell different conditions apart, which may help future care.
Cape Town, Western CapeAges 18 years+ - NCT06253715RecruitingPhase 3
Shorter TB treatment for children
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
ChennaiAges birth–9 years - NCT03044509Recruiting
Testing to diagnose tuberculosis in Swiss children
This trial studies how to diagnose tuberculosis (TB) in children and teens when they are being checked after possible exposure or because TB is suspected. It may help doctors figure out faster and more accurately who has TB infection or disease.
AarauAges Up to 17 years - NCT01212003Recruiting
Study of how tuberculosis develops over time
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
Bethesda, MarylandAges 2–100 - NCT05534750RecruitingPhase 2
Early test of two antibiotics for new lung TB
This trial tests how quickly two antibiotics (tedizolid vs linezolid) can kill tuberculosis germs in the lungs after a first TB infection is suspected. It may help doctors learn which option works faster and safely in the early treatment phase.
ParisAges 18–75 - NCT06728930Enrolling by invitation
New test for diagnosing latent and active TB
This study tests a new type of lab test to find TB bacteria more accurately. It is for people who are being checked for latent (hidden) TB infection, or who have just been diagnosed with active TB. The goal is to see if the new test can help doctors diagnose TB better and faster.
LondonAges 18 years+ - NCT07152639RecruitingPhase 3
New skin test for tuberculosis in people 3 and older
This trial tests a new skin test (EEC) to see if it can accurately detect tuberculosis infection in people aged 3 and older. It compares the test's results in healthy people, people with TB, and people with other lung diseases to check how well it works.
Beijing, Beijing MunicipalityAges 3 years+ - NCT06751706Enrolling by invitation
Testing blood for TB in patients and their household contacts
This study looks for TB bacteria in the blood of people with active tuberculosis and their close contacts at home. It aims to find better ways to detect TB early and prevent its spread.
KampalaAges 18 years+ - NCT06531772Recruiting
Study of TB and HIV co-infection outcomes
This study looks at the health of people who have both tuberculosis (TB) and HIV. It helps doctors understand how the two infections affect each other and what treatments work best.
AsyutAges Any age - NCT06262282Enrolling by invitation
Phage therapy for stubborn NTM infection in cystic fibrosis
This trial tests whether a special virus therapy (phage) can help clear stubborn NTM lung infections in people with cystic fibrosis who have been on antibiotics for over a year without success. Participants will continue their antibiotics while receiving the phages.
Birmingham, AlabamaAges 6 years+ - NCT06580639Recruiting
Measuring immune control of tuberculosis
This study looks at how well your immune system controls tuberculosis (TB) bacteria. It uses a blood test to measure immune responses in healthy people and those who have been vaccinated against TB.
KalmarAges 18 years+
Hear when a new Mycobacterium Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for mycobacterium tuberculosis?
- Yes. Clin2 currently lists 13 recruiting mycobacterium tuberculosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a mycobacterium tuberculosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a mycobacterium tuberculosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.